Condition (MeSH)
Aging, Premature
ClinicalTrials.gov lists 15 trials for Aging, Premature or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
15 of the 15 trials are tagged with Aging, Premature itself; the rest are tagged with a narrower condition beneath it.
When did Aging, Premature trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2024 | 1 |
| 2023 | 2 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 1 |
| 2019 | 2 |
| 2017 | 3 |
| 2015 | 1 |
| 2007 | 1 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 1.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 15 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Aging, Premature trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 2 |
| Not applicable | 5 |
| Observational | 7 |
How many Aging, Premature trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Active, not recruiting | 2 |
| Completed | 8 |
| Unknown status | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Aging, Premature trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| AB Biotics, SA | 1 |
| Bioenergy Life Science, Inc. | 1 |
| Dr. Korman Laboratories Ltd. | 1 |
| National Human Genome Research Institute (NHGRI) | 1 |
Which drugs are being tested for Aging, Premature? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Quercetin | 1 |
| DASATINIB | 1 |
Interventions as named in the registry (6)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Estradiol Vaginal Insert | 1 |
| Probiotic | 1 |
| Prebiotic | 1 |
| Vaginal estradiol tablets | 1 |
| Scopolamine Injectable Product | 1 |
Showing 5 of 6 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Aging, Premature trials report? (6)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Fractured Right Distal Fibula | 1 | 1 |
| Hospitalization for Chest Pain | 1 | 1 |
| Hospitalization for Gastrointestinal Bleed (GIB) | 1 | 1 |
| Hypoglycemia | 1 | 1 |
| Liver Cancer | 1 | 1 |
Showing 5 of 6 adverse events.
Which publications cover Aging, Premature? (22)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Premature aging of circulating T cells predicts all-cause mortality in hemodialysis patients. | BMC nephrology | 2020 | Yes |
| Reproductive Health in Xeroderma Pigmentosum: Features of Premature Aging. | Obstetrics and gynecology | 2019 | Yes |
| A pilot investigation of the impact of smoking cessation on biological age. | The American journal on addictions | 2017 | Yes |
| GLP-1-RA Corrects Mitochondrial Labile Iron Accumulation and Improves β-Cell Function in Type 2 Wolfram Syndrome. | The Journal of clinical endocrinology and metabolism | 2016 | Yes |
| Inflammation and oxidative stress as biomarkers of premature aging in persons with intellectual disability. | Research in developmental disabilities | 2012 | Yes |
Showing 5 of 22 publications.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Premature aging | 79389 | Exact | Orphadata Science knowledge files, Product 1 |
| Premature aging | 79389 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and sub-conditions in mesh.